Stock Rich List
Nasdaq: NVCT

Nuvectis Pharma insiders

The officers, directors and 10% owners of Nuvectis Pharma, Inc. who hold the most stock, valued at the live NVCT price.

$19.84
NVCT today −$450K (−2.22%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
4
Their NVCT stock
$148M
Market value
$680M
Held by ranked insiders
21.7%

Insiders by value of NVCT holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Ron BentsurChairman & CEO3,688,424$73.2M10.8%1923rd
2Enrique PoradosuChief Science & Business Off1,806,319$35.8M5.27%3269th
3Shay ShemeshChief Dev. & Ops. Officer1,793,068$35.6M5.23%3280th
4Kenneth HobermanDirector168,140$3.3M0.49%4911th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Nuvectis Pharma; see each profile for the filing.